Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes
Travere Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $47.18
+0.5% in 7d after detection
Post-detection moves
1h
—
1d
-0.1%
3d
+0.4%
7d
+0.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS